On the Promise of Pharmacotherapies Targeted at Cognitive and Neurodegenerative Components of Down Syndrome

Publisher： Karger

E-ISSN： 1421-9859|33|5|414-427

ISSN： 0378-5866

Source： Developmental Neuroscience, Vol.33, Iss.5, 2011-09, pp. : 414-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mouse Models for Down Syndrome-Associated Developmental Cognitive Disabilities

By  

Developmental Neuroscience, Vol. 33, Iss. 5, 2011-08 ,pp. : 404-413

Karger

Access to resources Recommend Favorite

Environmental Enrichment Rescues Postnatal Neurogenesis Defect in the Male and Female Ts65Dn Mouse Model of Down Syndrome

By  

Developmental Neuroscience, Vol. 33, Iss. 5, 2011-08 ,pp. : 428-441

Karger

Access to resources Recommend Favorite

Abnormal MicroRNA Expression in Ts65Dn Hippocampus and Whole Blood: Contributions to Down Syndrome Phenotypes

By  

Developmental Neuroscience, Vol. 33, Iss. 5, 2011-10 ,pp. : 451-467

Karger

Access to resources Recommend Favorite

A Critical Period in Cortical Interneuron Neurogenesis in Down Syndrome Revealed by Human Neural Progenitor Cells

By  

Developmental Neuroscience, Vol. 31, Iss. 6, 2009-09 ,pp. : 497-510

Karger

Access to resources Recommend Favorite

G-Protein-Associated Signal Transduction Processes Are Restored after Postweaning Environmental Enrichment in Ts65Dn, a Down Syndrome Mouse Model

By  

Developmental Neuroscience, Vol. 33, Iss. 5, 2011-08 ,pp. : 442-450

Karger

Access to resources Recommend Favorite